ACA
OGN icon

Aptus Capital Advisors’s Organon & Co OGN Stock Holding History

Aptus Capital Advisors’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-192,507
Closed -$3.62M – 1219
2024
Q1 		$3.62M Buy
192,507
+1,378
+0.7% +$23.6K 0.07% 217
2023
Q4 		$2.76M Buy
+191,129
New +$2.6M 0.08% 191

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SSM
Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aptus Capital Advisors's OGN Position: Q2 2024 in Review

Aptus Capital Advisors sold out of Organon & Co (OGN) in Q2 2024, closing a stake of 192,507 shares — an estimated $3.62M sold.

Aptus Capital Advisors first reported a position in OGN in Q4 2023 and held it in 2 quarters. The position peaked at $3.62M in Q1 2024. 725 funds tracked by Wall St. Rank hold OGN as of Q2 2024.

  • Aptus Capital Advisors reported no remaining Organon & Co position as of Q2 2024 after selling out during the quarter.
  • Aptus Capital Advisors sold 192,507 Organon & Co shares in Q2 2024, an estimated $3.62M.
  • Aptus Capital Advisors first reported a position in Organon & Co in Q4 2023 and held it in 2 quarters.
  • Aptus Capital Advisors's Organon & Co position peaked at $3.62M in Q1 2024.
  • 725 funds tracked by Wall St. Rank held Organon & Co as of Q2 2024.

Based on Aptus Capital Advisors's 13F filing for Q2 2024, filed 31 Jul 2024.